vidarabine phosphate has been researched along with Waldenstrom Macroglobulinemia in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (75.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Greenberg, HE; Rossoff, LJ; Stoica, GS | 1 |
| Chie, I; Fukagawa, S; Fukuda, R; Hotta, T; Kawada, H; Kojima, S; Ogawa, Y; Onizuka, M; Shimada, M; Suzuki, R; Takagi, A; Urano, T; Yanagi, H | 1 |
| Cabanillas, F; Dimopoulos, M; Estey, E; Gandhi, V; Kantarjian, H; Keating, MJ; Kemena, A; O'Brien, S; Plunkett, W; Robertson, LE | 1 |
| Alexanian, R; Dimopoulos, MA; Kantarjian, H; Keating, M; Weber, DM | 1 |
| Binet, JL | 1 |
| Keating, MJ; McLaughlin, P; Robertson, LE | 1 |
| Barbui, T; Coiffier, B; Foran, JM; Hiddemann, W; Johnson, SA; Lister, TA; Norton, AJ; Radford, JA; Rohatiner, AZ; Tollerfield, SM; Wilson, MP | 1 |
| Alexanian, R; Kantarjian, HM; Keating, MJ; Koller, CA; Kurzrock, R | 1 |
3 review(s) available for vidarabine phosphate and Waldenstrom Macroglobulinemia
| Article | Year |
|---|---|
Fludarabine phosphate: a new active agent in hematologic malignancies.
Topics: Animals; Clinical Trials as Topic; Hematologic Diseases; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma; Vidarabine Phosphate; Waldenstrom Macroglobulinemia | 1994 |
Fludarabine phosphate in chronic lymphoproliferative diseases. The French Group on CLL.
Topics: Antimetabolites, Antineoplastic; Clinical Trials, Phase II as Topic; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Non-Hodgkin; Lymphoproliferative Disorders; Vidarabine Phosphate; Waldenstrom Macroglobulinemia | 1993 |
Fludarabine phosphate in lymphoma: an important new therapeutic agent.
Topics: Antimetabolites, Antineoplastic; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Hodgkin Disease; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma; Multiple Myeloma; Vidarabine Phosphate; Waldenstrom Macroglobulinemia | 1996 |
1 trial(s) available for vidarabine phosphate and Waldenstrom Macroglobulinemia
| Article | Year |
|---|---|
Multicenter phase II study of fludarabine phosphate for patients with newly diagnosed lymphoplasmacytoid lymphoma, Waldenström's macroglobulinemia, and mantle-cell lymphoma.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Disease Progression; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Survival Analysis; Vidarabine Phosphate; Waldenstrom Macroglobulinemia | 1999 |
4 other study(ies) available for vidarabine phosphate and Waldenstrom Macroglobulinemia
| Article | Year |
|---|---|
Corticosteroid responsive fludarabine pulmonary toxicity.
Topics: Antimetabolites, Antineoplastic; Female; Glucocorticoids; Humans; Lung Diseases; Middle Aged; Vidarabine Phosphate; Waldenstrom Macroglobulinemia | 2002 |
Pulmonary non-caseating granuloma in Waldenström macroglobulinemia.
Topics: Antimetabolites, Antineoplastic; Humans; Male; Middle Aged; Plasma Cell Granuloma, Pulmonary; Radiography; Treatment Outcome; Vidarabine Phosphate; Waldenstrom Macroglobulinemia | 2005 |
2Chlorodeoxyadenosine therapy of patients with Waldenström macroglobulinemia previously treated with fludarabine.
Topics: Aged; Antimetabolites, Antineoplastic; Cladribine; Drug Resistance; Female; Humans; Male; Middle Aged; Recurrence; Treatment Outcome; Vidarabine Phosphate; Waldenstrom Macroglobulinemia | 1994 |
Fludarabine therapy in macroglobulinemic lymphoma.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Arabinonucleotides; Female; Humans; Infusions, Intravenous; Lymphoma; Macroglobulins; Male; Middle Aged; Vidarabine Phosphate; Waldenstrom Macroglobulinemia | 1990 |